Novartis Oncology Receives Prix Galien Award for Discovery of the Decade
Oct 28, 2016
This year, The Galien Foundation, an organization devoted to fostering, recognizing and rewarding excellence in scientific innovation, celebrated the 10 year anniversary of its internationally recognized award: the Prix Galien USA. To commemorate this occasion and recognize the companies that have helped make the past ten years the most productive for research in history, it has decided to highlight three products - a pharmaceutical drug, a biotech drug and a medical or diagnostic technology - as the Discovery of the Decade.
At Novartis Oncology, we are proud to be the recipients of the first ever Discovery of the Decade award for Best Pharmaceutical Product from this esteemed organization. Because of our commitment to researching and developing innovative oncology treatments, we are honored to be recognized for doing what we can to help improve the lives of those affected by cancer.
Our dedication to research has allowed us to unravel how cancers develop and create treatments that have turned once fatal conditions into manageable diseases. We look forward to continuing to revolutionize research, so we can try to help people live longer and with a better quality of life, giving them more time to do the things that matter to them.